Innoviva, Inc. INVA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-10-05
Innoviva, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Basso Stephen | Chief Financial Officer | 2026-05-20 | Tax withheld | 559 | $22.24 |
| Raifeld Pavel | Chief Executive Officer | 2026-05-20 | Tax withheld | 1,130 | $22.24 |
| Zhen Marianne | Chief Accounting Officer | 2026-05-20 | Tax withheld | 1,127 | $22.24 |
| Linden Josephine | director | 2026-05-18 | Grant | 5,733 | — |
| Linden Josephine | director | 2026-05-18 | Grant | 9,461 | — |
| Basso Stephen | Chief Financial Officer | 2026-05-15 | Grant | 1,123 | — |
| Raifeld Pavel | Chief Executive Officer | 2026-05-15 | Grant | 1,123 | — |
| DiPaolo Mark | director | 2026-05-04 | Grant | 9,786 | — |
Source: SEC EDGAR filings · CIK 0001080014 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.